课题基金 / 基金详情

Functional analysis of miR-375, a candidate of tumor suppressor miRNA in gastric cancer

Functional analysis of miR-375, a candidate of tumor suppressor miRNA in gastric cancer
胃癌抑癌miRNA候选物miR-375的功能分析
批准号:
22790349
负责人:
TSUKAMOTO Yoshiyuki
金额:
$2.5万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2010
资助国家:
日本
项目状态:
已结题
起止时间:
2010 至 2011

项目摘要

项目成果

TSUKAMOTO Yoshiyuki的其他基金

相似基金

相关文献

中文摘要
翻译
在本研究中,我们发现miRNA-375(miR-375)下调最多,其在胃癌细胞中的异位表达通过caspase介导的凋亡途径显著降低细胞活力。有趣的是,我们发现miR-375的表达抑制了PDK1的表达,PDK1是miR-375的直接靶点,随后抑制了Akt的磷酸化。通过基因表达芯片进一步分析发现,在转染miR-375的细胞中,14-3-3 -3zeta(一种有效的抗凋亡基因)的mRNA和蛋白水平均显著下调。在14-3-3zeta mRNA的3‘非翻译区(UTR)含有miR-375结合序列的荧光素酶报告基因的活性被miR-375的异位表达抑制,这表明miR-375靶向14-3-3zeta的3’ UTR。此外,在胃癌细胞中敲低PDK1或14-3-3zeta均可诱导caspase激活,在转染miR-375的细胞中也观察到这一现象,这表明miR-375可能至少部分通过下调PDK1和14-3-3zeta来发挥其促凋亡功能。综上所述,我们提出miR-375是胃癌中的候选肿瘤抑制miRNA
英文摘要
In this study, we found that miRNA-375(miR-375) was the most downregulated and that its ectopic expression in gastric carcinoma cells markedly reduced cell viability via the caspase-mediated apoptosis pathway. Interestingly, we found that expression of miR-375 inhibited expression of PDK1, which is a direct target of miR-375, followed by suppression of Akt phosphorylation. Further analysis by gene expression microarray revealed that 14-3-3zeta, a potent antiapoptotic gene, was significantly downregulated at both the mRNA and protein levels in cells transfected with miR-375. The activity of a luciferase reporter containing the miR-375 binding sequence at the 3' untranslated region(UTR) of 14-3-3zeta mRNA was repressed by the ectopic expression of miR-375, suggesting that miR-375 targets the 3' UTR of 14-3-3zeta. In addition, knockdown of either PDK1 or 14-3-3zeta in gastric carcinoma cells induced caspase activation, which was also observed in miR-375-transfected cells, suggesting that miR-375 may exert its proapoptotic function, at least in part, through the downregulation of PDK1 and 14-3-3zeta. Taken together, we propose that miR-375 is a candidate tumor suppressor miRNA in gastric carcinoma
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1371/journal.pone.0022313
发表时间: 2011
期刊: PloS one
影响因子: 3.7
作者: [Kuroda A, Tsukamoto Y, Nguyen LT, Noguchi T, Takeuchi I, Uchida M, Uchida T, Hijiya N, Nakada C, Okimoto T, Kodama M, Murakami K, Matsuura K, Seto M, Ito H, Fujioka T, Moriyama M]
通讯作者: Moriyama M
MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta.
MicroRNA-375 在胃癌中下调,并通过靶向 PDK1 和 14-3-3zeta 来调节细胞存活。
DOI: --
发表时间: 2010
期刊: Cancer Res. 70
影响因子: --
作者: [Tsukamoto, Y]
通讯作者: Y
胃癌におけるマイクロRNA発現
胃癌中微小RNA的表达
DOI: --
发表时间: 2011
期刊:
影响因子: --
作者: [成松隆弘, ほか]
通讯作者: ほか
DOI: 10.1111/j.1349-7006.2011.02176.x
发表时间: 2012-03-01
期刊: CANCER SCIENCE
影响因子: 5.7
作者: [Inoue, Toru, Matsuura, Keiko, Moriyama, Masatsugu]
通讯作者: Moriyama, Masatsugu
共 6 条
    Overexpression of DDX27 in gastric cancer(Fostering Joint International Research)
    • 批准号:
      15KK0351
    • 项目类别:
      Fund for the Promotion of Joint International Research (Fostering Joint International Research)
    • 资助金额:
      $6.24万
    • 财政年份:
      2016
    • 负责人:
      TSUKAMOTO Yoshiyuki
    • 依托单位:
    Screening of target genes for chromosome 20q
    • 批准号:
      24590446
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.41万
    • 财政年份:
      2012
    • 负责人:
      TSUKAMOTO Yoshiyuki
    • 依托单位:
    Genomic profiling of gastric carcinoma in situ by array-based comparative genomic hybridization
    • 批准号:
      20790286
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.66万
    • 财政年份:
      2008
    • 负责人:
      TSUKAMOTO Yoshiyuki
    • 依托单位:
    国内基金
    海外基金
    幽门螺杆菌诱导中性粒细胞CXCL8-C3AR1轴促进胃癌免疫逃逸的机制研究
    • 批准号:
      2026JJ82697
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      邹品衡
    • 依托单位:
    Circ_0009594通过招募HNRNPA1上调NRF2表达抑制胃癌铁死亡的作用与机制研究
    • 批准号:
      2026JJ82174
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      肖华
    • 依托单位:
    基于多重组学液体活检术的胃癌人工智能精准诊疗体系构建及实践
    • 批准号:
      2026JJ81931
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      田继东
    • 依托单位:
    YBX1介导的HOXA9 mRNA稳定性影响c-MYC转录在胃癌进展中的机制研究